14195435 - GAU: 3993
`
`March3, 2014
`
`Howard C. Rootetal.
`
`
`
`; H
`
`Receipt Date: 07/23/2014
`
`
`
` Complete if Known
`Substitute for form 1449/PTO
`
`14/195,435
`
`
`
`INFORMATION DISCLOSURE
`
`
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary)
`
`
`
`
`
`
`
`
`
`
`NON PATENT LITERATURE DOCUMENTS
`INITIAL”
` |]
`
`EXAMINER
`
`Cite
`Include nameof the author (in CAPITAL LETTERS),title of the article (when appropriate), title of the
`No.!
`item (book, magazine, journal, serial, symposium,catalog, etc.), date, page(s), volume-issue number(s),
`
`
`publisher, city and/or country where published
`
`
`
`Bo
`orArt statement, Dated
`[SEL December20, 2013,cited inCivil No. 0:13-cv-01172-JRT-SER
`-
`-
`.
`
`
`||__| Defendant, Boston Scientific Corporation’s First Amended Prior Art Statement
`
`>
`
`
`
`P|||Datea |
`Plaintiff, Vascular Solutions, Inc.’s Response to Defendant Boston Scientific
`P|
`
`ivil No.0:
`semraaranaransareavel| eeerceeeeeeeeeereeeern <orporation's Prior Art Statement, Dated January 23,2014, Civil No, 0:13-cv-|
`Corporation’s
`Pri
`t, Dated January
`23,
`20
`
`|ss 01172-JRT-SER.
`
`e to Defendant BostonScientific
`
`
`mn
`a atad
`:
`f
`fi
`a4
`
`
`
`
`
`
`DATE
`EXAMINER
`09/25/2015
`CONSIDERED
`/CATHERINE WILLIAMS /
`SIGNATURE
`*EXAMINER: Initial if reference considered, whether or notcitation is in conformance with MPEP 609. Draw line through citation if notin
`conformanceandnot considered. Include copy of this form with next communication to applicant. 'Applicant’s uniquecitation designation
`number(optional). 7Applicantis to place a check mark here if English language Translation is attached.
`This collection of information is required by 37 CFR 1.98. The information is required to obtain or retain a benefit by the public whichis to file
`
`
`(and by the USPTOto process) an application. Confidentiality is governed by 35 U.S.C, 122 and 37 CFR 1.14. This collection is estimated to
`
`
`take 120 minutes to complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary
`
`
`depending upon the individual case. Any comments on the amountof time you require to complete this form and/or suggestions for reducing
`
`
`this burden, should be sent to the Chief Information Officer, U.S. Patent and Trademark Office, U.S. Department of Commerce, Washington,
`
`
`DC 20231. DO NOT SEND FEES OR COMPLETED FORMSTO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450
`
`
`
`Alexandria, VA 22313-1450.
`
` ifyou need assistance in completing theform, call 1-800-PTO-9199 (1-800-786-9199) and select option 2.
`
`
`
`